Angiogenesis regulatory factors in the vitreous from patients with proliferative diabetic retinopathy

Acta Diabetologica

Volumn 50, Issue 4, 2013, Pages 545-551

  Abu El Asrar, Ahmed M ^a,b   Nawaz, Mohd Imtiaz ^a   Kangave, Dustan ^a   Siddiquei, Mohammed Miraj ^a   Ola, Mohammad Shamsul ^a   Opdenakker, Ghislain ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Angiogenesis; Proliferative diabetic retinopathy; Soluble vascular endothelial growth factor receptor 1, thrombospondin

Indexed keywords

THROMBOSPONDIN 1; THROMBOSPONDIN 2; VASCULOTROPIN RECEPTOR 1;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RETINA DETACHMENT; UPREGULATION; VITREOUS BODY; VITREOUS HEMORRHAGE;

ANGIOGENESIS INDUCING AGENTS; DIABETIC RETINOPATHY; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; THROMBOSPONDIN 1; THROMBOSPONDINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VITREOUS BODY;

EID: 84884908278     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-011-0330-9     Document Type: Article

References (26)

1. Spranger J, Pfeiffer AP (2001) New concepts in pathogenesis and treatment of diabetic retinopathy. Exp Clin Endocrinol Diabetes 109:S438-S450 (Pubitemid 32586079)
2. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285:245-248 (Pubitemid 29329995)
3. Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H (2008) Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy. Ophthalmology 115:1916-1922
4. Shibuya M (2006) Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 39:469-478 (Pubitemid 44714526)
5. Wu FTH, Stefanini MO, Gabhann FM, Kontos CD, Annex BH, Popel AS (2010) A system biology perspective on sVEGFR-1: its biological function, pathogenic role and therapeutic use. J Cell Mol Med 14:528-552
6. Zhang X, Lawler J (2007) Thrombospondin-based antiangiogenic therapy. Microvasc Res 74:90-99 (Pubitemid 350064284)
7. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL (1994) Vascular endothelial growth factor in ocular fluid in patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487 (Pubitemid 24356306)
8. Rota R, Riccioni T, Zaccarini M, Lamartina S, Gallo AD, Fusco A, Kovesdi I, Balestrazzi E, Abeni DC, Ali RR, Capogrossi MC (2004) Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer. J Gene Med 6:992-1002 (Pubitemid 40228114)
9. Kyriakides TR, Tam JW (1999) Bornstein. Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene. J Invest Dermatol 113:782-787
10. Lin T-N, Kim G-M, Chen J-J, Cheung W-M, He YY, Hsu CY (2003) Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion. Stroke 34:177-186 (Pubitemid 36070819)
11. Hawighorst T, Velasco P, Streit M, Hong Y-K, Kyriakides TR, Brown LF, Bornstein P, Detmar M (2001) Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism. EMBO J 20:2631-2640 (Pubitemid 32938548)
12. Streit M, Riccardi L, Velasco P, Brown LF, Hawighorst T, Bornstein P, Detmar M (1999) Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci USA 96:14888-14893 (Pubitemid 30019735)
13. Noh Y-H, Matsuda K, Hong Y-K, Kunstfeld R, Riccardi L, Koch M, Oura H, Dadras SS, Streit M, Detmar M (2003) An N-terminal 80 kDa recombinant fragment of human thrombopsondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo. J Invest Dermatol 121:1536-1543 (Pubitemid 38005510)
14. Koch M, Hussein F, Woeste A, Gründker C, Frontzek K, Emons G, Hawighorst T (2011) CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo. Breast Cancer Res Treat 128:337-346
15. MacLauchlan S, Skokos EA, Agah A, Zeng J, Tian W, Davidson JM, Bornstein P, Kyriakides TR (2009) Enhanced angiogenesis and reduced contraction in thrombospondin-2-null wounds is associated with increased levels of matrix metalloproteinases-2 and-9 and soluble VEGF. J Histochem Cytochem 57:301-313
16. Kyriakides TR, Zhu Y-H, Yang Z, Huynh G, Bornstein P (2001) Altered extracellular matrix remodeling and angiogenesis in sponge granulomas of thrombospondin 2-null mice. Am J Pathol 159:1255-1262 (Pubitemid 32947955)
17. Krady MM, Zeng J, Yu J, MacLauchlan S, Skokos EA, Tian W, Bornstein P, Sessa WC, Kyriakides TR (2008) Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis. Am J Pathol 173:879-891
18. Park YW, Kang YM, Butterfield J, Detmar M, Goronzy JJ, Weyand CM (2004) Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis. Am J Pathol 165:2087-2098 (Pubitemid 39578386)
19. Armstrong LC, Björkblom B, Hankenson KD, Siadak AW, Stiles CE, Bornstein P (2002) Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism. Mol Biol Cell 13:1893-1905 (Pubitemid 34651480)
20. Simantov R, Febbraio M, Silverstein RL (2005) The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein. Matrix Biol 24:27-34 (Pubitemid 40320896)
21. Adri VC, Kupriyanova TA, Deryugina EI, Quigley JP (2007) Human neutrophils uniquely release TIMP-Free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc Natl Acad Sci USA 104:20262-20267
22. Bergers G, Prekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Natl Cell Biol 2:737-744
23. Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML (2005) Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 169:681-691 (Pubitemid 41002860)
24. Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J (2006) Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Eur Cytokine Netw 17:155-165
25. Ogata N, Ando A, Uyama M, Matsumura M (2001) Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells. Graefes Arch Exp Ophthalmol 239:87-95 (Pubitemid 32288457)
26. Xiao M, McLeod D, Cranley J, Williams G, Boulton M (1999) Growth factor staining patterns in the pig retina following retinal laser photocoagulation. Br J Ophthalmol 83:728-736 (Pubitemid 29261666)